Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synaptic Changes in Parkinson Disease Assessed with in vivo Imaging
David Matuskey, Sule Tinaz, Kyle C. Wilcox, et al.
Annals of Neurology (2020) Vol. 87, Iss. 3, pp. 329-338
Open Access | Times Cited: 147

Showing 1-25 of 147 citing articles:

Biomarkers for neurodegenerative diseases
Oskar Hansson
Nature Medicine (2021) Vol. 27, Iss. 6, pp. 954-963
Open Access | Times Cited: 721
Solving neurodegeneration: common mechanisms and strategies for new treatments
Lauren K. Wareham, Shane A. Liddelow, Sally Temple, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 192
Fluid Biomarkers for Synaptic Dysfunction and Loss
Elena Camporesi, Johanna Nilsson, Ann Brinkmalm, et al.
Biomarker Insights (2020) Vol. 15, pp. 117727192095031-117727192095031
Open Access | Times Cited: 107
First-in-Human Evaluation of 18F-SynVesT-1, a Radioligand for PET Imaging of Synaptic Vesicle Glycoprotein 2A
Mika Naganawa, Songye Li, Nabeel Nabulsi, et al.
Journal of Nuclear Medicine (2020) Vol. 62, Iss. 4, pp. 561-567
Open Access | Times Cited: 92
The role of neuroimaging in Parkinson’s disease
Natasha Bidesi, Ida Vang Andersen, Albert D. Windhorst, et al.
Journal of Neurochemistry (2021) Vol. 159, Iss. 4, pp. 660-689
Open Access | Times Cited: 88
Loss of Presynaptic Terminal Integrity in the Substantia Nigra in Early Parkinson's Disease
Aline Delva, Donatienne Van Weehaeghe, Michel Koole, et al.
Movement Disorders (2020) Vol. 35, Iss. 11, pp. 1977-1986
Open Access | Times Cited: 74
In vivo evidence of lower synaptic vesicle density in schizophrenia
Rajiv Radhakrishnan, Patrick D. Skosnik, Mohini Ranganathan, et al.
Molecular Psychiatry (2021) Vol. 26, Iss. 12, pp. 7690-7698
Closed Access | Times Cited: 74
Molecular Mechanisms Underlying Synaptic and Axon Degeneration in Parkinson’s Disease
Nolwazi Z. Gcwensa, Drèson L. Russell, Rita M. Cowell, et al.
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 70
Imaging of Synaptic Density in Neurodegenerative Disorders
Richard E. Carson, Mika Naganawa, Takuya Toyonaga, et al.
Journal of Nuclear Medicine (2022) Vol. 63, Iss. Supplement 1, pp. 60S-67S
Open Access | Times Cited: 68
Synaptic Vesicle Glycoprotein 2A: Features and Functions
Rachele Rossi, Shokouh Arjmand, Simone Larsen Bærentzen, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 61
Reduced Synaptic Density in Patients with Lewy Body Dementia: An [11C]UCB‐J PET Imaging Study
Katrine B. Andersen, Allan K. Hansen, Malene Flensborg Damholdt, et al.
Movement Disorders (2021) Vol. 36, Iss. 9, pp. 2057-2065
Open Access | Times Cited: 56
Detecting Early Cognitive Decline in Alzheimer’s Disease with Brain Synaptic Structural and Functional Evaluation
Samo Ribarič
Biomedicines (2023) Vol. 11, Iss. 2, pp. 355-355
Open Access | Times Cited: 23
Regional differences in synaptic degeneration are linked to alpha-synuclein burden and axonal damage in Parkinson’s disease and dementia with Lewy bodies
Irene Frigerio, Maud M.A. Bouwman, Ruby T G M M Noordermeer, et al.
Acta Neuropathologica Communications (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 13
Dopamine Signaling in Substantia Nigra and Its Impact on Locomotor Function—Not a New Concept, but Neglected Reality
Michael F. Salvatore
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1131-1131
Open Access | Times Cited: 13
In vivo imaging of synaptic density in neurodegenerative disorders with positron emission tomography: A systematic review
M. de Visser, John T. O’Brien, Elijah Mak
Ageing Research Reviews (2024) Vol. 94, pp. 102197-102197
Open Access | Times Cited: 9
Synaptic loss and its association with symptom severity in Parkinson’s disease
Sophie Holmes, Praveen Honhar, Sule Tinaz, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 9
Transcriptionally downregulated GABAergic genes associated with synaptic density network dysfunction in temporal lobe epilepsy
Rong Li, Ling Xiao, Honghao Han, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Closed Access | Times Cited: 1
PET imaging reveals early and progressive dopaminergic deficits after intra-striatal injection of preformed alpha-synuclein fibrils in rats
Majken Borup Thomsen, Sara A. Ferreira, Anna Christina Schacht, et al.
Neurobiology of Disease (2020) Vol. 149, pp. 105229-105229
Open Access | Times Cited: 59
Mitochondrial Complex 1, Sigma 1, and Synaptic Vesicle 2A in Early Drug‐Naive Parkinson's Disease
Heather Wilson, Gennaro Pagano, Edoardo Rosario de Natale, et al.
Movement Disorders (2020) Vol. 35, Iss. 8, pp. 1416-1427
Open Access | Times Cited: 57
Synaptic density in healthy human aging is not influenced by age or sex: a 11C-UCB-J PET study
Laura Michiels, Aline Delva, June van Aalst, et al.
NeuroImage (2021) Vol. 232, pp. 117877-117877
Open Access | Times Cited: 46
Positron emission tomography in multiple sclerosis — straight to the target
Benedetta Bodini, Mattéo Tonietto, Laura Airas, et al.
Nature Reviews Neurology (2021) Vol. 17, Iss. 11, pp. 663-675
Closed Access | Times Cited: 46
Assessment of test-retest reproducibility of [18F]SynVesT-1, a novel radiotracer for PET imaging of synaptic vesicle glycoprotein 2A
Songye Li, Mika Naganawa, Richard Pracitto, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2021) Vol. 48, Iss. 5, pp. 1327-1338
Closed Access | Times Cited: 43
Spatial decrease of synaptic density in amnestic mild cognitive impairment follows the tau build-up pattern
Greet Vanderlinden, Jenny Ceccarini, Thomas Vande Casteele, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 10, pp. 4244-4251
Closed Access | Times Cited: 34
How should we be using biomarkers in trials of disease modification in Parkinson’s disease?
Nirosen Vijiaratnam, Thomas Foltynie
Brain (2023) Vol. 146, Iss. 12, pp. 4845-4869
Open Access | Times Cited: 19
Synaptic Loss in Spinocerebellar Ataxia Type 3 Revealed by SV2A Positron Emission Tomography
Zhao Chen, Guang Liao, Na Wan, et al.
Movement Disorders (2023) Vol. 38, Iss. 6, pp. 978-989
Closed Access | Times Cited: 16
Page 1 - Next Page

Scroll to top